99 related articles for article (PubMed ID: 20013813)
1. Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo.
Chow EC; Sun H; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2010 Jan; 31(1):91-108. PubMed ID: 20013813
[TBL] [Abstract][Full Text] [Related]
2. 1alpha,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo.
Chow EC; Maeng HJ; Liu S; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2009 Nov; 30(8):457-75. PubMed ID: 19753549
[TBL] [Abstract][Full Text] [Related]
3. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
4. 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac.
Maeng HJ; Durk MR; Chow EC; Ghoneim R; Pang KS
Biopharm Drug Dispos; 2011 Mar; 32(2):112-25. PubMed ID: 21341280
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.
Khan AA; Chow EC; van Loenen-Weemaes AM; Porte RJ; Pang KS; Groothuis GM
Eur J Pharm Sci; 2009 May; 37(2):115-25. PubMed ID: 19429418
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of doxercalciferol (1α-hydroxyvitamin D₂) versus calcitriol (1α,25-dihydroxyvitamin D₃) on the expression of transporters and enzymes in the rat in vivo.
Chow EC; Sondervan M; Jin C; Groothuis GM; Pang KS
J Pharm Sci; 2011 Apr; 100(4):1594-604. PubMed ID: 20967888
[TBL] [Abstract][Full Text] [Related]
7. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
Chow EC; Durk MR; Cummins CL; Pang KS
J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
Chow EC; Durk MR; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
[TBL] [Abstract][Full Text] [Related]
9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
10. 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro.
Zierold C; Mings JA; Deluca HF
Mol Pharmacol; 2006 May; 69(5):1740-7. PubMed ID: 16484501
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
12. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat.
Sriussadaporn S; Wong MS; Pike JW; Favus MJ
J Bone Miner Res; 1995 Feb; 10(2):271-80. PubMed ID: 7754807
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha,25-dihydroxyvitamin D3.
Okano T; Tsugawa N; Morishita A; Kato S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):335-8. PubMed ID: 15225796
[TBL] [Abstract][Full Text] [Related]
14. Capacity of 1,25-dihydroxyvitamin D to stimulate expression of calbindin D changes with age in the rat.
Armbrecht HJ; Boltz MA; Christakos S; Bruns ME
Arch Biochem Biophys; 1998 Apr; 352(2):159-64. PubMed ID: 9587402
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
Karnauskas AJ; van Leeuwen JP; van den Bemd GJ; Kathpalia PP; DeLuca HF; Bushinsky DA; Favus MJ
J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Dietary restriction of calcium, phosphorus, and vitamin D elicits differential regulation of the mRNAs for avian intestinal calbindin-D28k and the 1,25-dihydroxyvitamin D3 receptor.
Meyer J; Fullmer CS; Wasserman RH; Komm BS; Haussler MR
J Bone Miner Res; 1992 Apr; 7(4):441-8. PubMed ID: 1376958
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]